Heron Therapeutics, Inc.
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported -0.10 USD per share, beating the -0.01 USD estimate by -566.67%. Revenue for the same period reached 38.21 M USD, despite the estimate of 39.03 M USD. For the next quarter, analysts expect -0.02 USD in earnings per share and 40.08 M USD in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise